about
Graft-versus-host disease: state of the science.Modeling the relationship between progression-free survival and overall survival: the phase II/III trial.A multi-arm multi-stage clinical trial design for binary outcomes with application to tuberculosisEvaluating many treatments and biomarkers in oncology: a new designAdvances in Statistical Approaches Oncology Drug Development.Evaluation of a multi-arm multi-stage Bayesian design for phase II drug selection trials - an example in hemato-oncologyRandomized phase II trial designs with biomarkers.ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up.Adaptive trial designs: a review of barriers and opportunitiesDesign Issues in Randomized Clinical Trials of Maintenance Therapies.Statistical challenges in the evaluation of treatments for small patient populations.New challenges for comparative effectiveness in oncology: choice of primary end points for randomized clinical trials.Decade in review--clinical trials: shifting paradigms in cancer clinical trial design.Clinical trials in gynecologic oncology: Past, present, and future.Adaptive Clinical Trials: Advantages and Disadvantages of Various Adaptive Design Elements.Bias, Operational Bias, and Generalizability in Phase II/III Trials.ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
P2860
Q33977923-5DBE2C9D-A028-4C7E-AF7A-DF649CCFEBD2Q34040130-80B81FC0-E254-4FAA-9DC8-76E0C8451D12Q35042658-539662B9-237C-415E-8DF9-906EB7797CE4Q35379179-7C82BF67-B46B-4DDF-87B9-B7D66F5475B2Q35565672-37E26181-E2A9-4B4A-BE22-403F3FBFE046Q36036648-73C7E87B-7D55-44BD-B754-55B49F8459F1Q36212448-F7F54900-E63D-4F7A-B1D5-D20FCE46AAD3Q36372293-9B424F1C-49F2-4FE0-A3D1-EE525DB3C318Q36460054-AFC9D8E1-D2DF-4319-B977-EACC3574D535Q36848078-E2ED5438-23A1-4849-A5AE-66044B703465Q38093778-375A21D4-59C9-4BB5-BD36-64D3D96C3D40Q38162911-067729F5-D9FE-4407-9734-E5E7D3CA620DQ44580889-59CDCF41-D6EE-4C9E-81C0-CB90C66383FDQ47796770-4413F2EC-1BB7-41A7-9012-D8D2989D7AC3Q52690719-BAFFE66F-6FDB-4413-8BA4-05E4E2596EE5Q53281780-B33C3B74-8F1C-4A55-92B4-DFFFE1642548Q57903637-A0882E75-D065-4FDA-92DF-203B4FED4482
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Design issues in randomized phase II/III trials.
@ast
Design issues in randomized phase II/III trials.
@en
type
label
Design issues in randomized phase II/III trials.
@ast
Design issues in randomized phase II/III trials.
@en
prefLabel
Design issues in randomized phase II/III trials.
@ast
Design issues in randomized phase II/III trials.
@en
P2093
P2860
P3181
P356
P1476
Design issues in randomized phase II/III trials.
@en
P2093
Edward L Korn
Jeffrey S Abrams
Susan Halabi
P2860
P304
P356
10.1200/JCO.2011.38.5732
P407
P577
2012-01-23T00:00:00Z